Conference scene

Gérard Siest; Rui Medeiros; Bohuslav Melichar; Maria Stathopoulou; Ron H.N. Van Schaik; Ramon Cacabelos; Peter Meier Abt; Carolino Monteiro; David Gurwitz; Jao Queiroz; Helder Mota-Filipe; Ndieye Coumba Ndiaye; Sophie Visvikis-Siest

doi:10.2217/pgs.14.35

Conference scene

Gérard Siest^*, Rui Medeiros, Bohuslav Melichar, Maria Stathopoulou, Ron H.N. Van Schaik, Ramon Cacabelos, Peter Meier Abt, Carolino Monteiro, David Gurwitz, Jao Queiroz, Helder Mota-Filipe, Ndieye Coumba Ndiaye, Sophie Visvikis-Siest

^*Corresponding author for this work

Human Molecular Genetics Biochemistry

Research output: Contribution to journal › Article › peer-review

Abstract

The second international European Society of Pharmacogenomics and Theranostics (ESPT) conference was organized in Lisbon, Portugal, and attracted 250 participants from 37 different countries. The participants could listen to 50 oral presentations, participate in five lunch symposia and were able to view 83 posters and an exhibition. The first part of this Conference Scene will focus on the pharmacogenomics and biomarkers used in medical oncology, and in particular solid tumors. In addition, this article covers the two keynote conference introductory lectures by Ann K Daly and Magnus Ingelman-Sundberg. The second part of this article will discuss the clinical implementation of pharmacogenomic tests; the role of transports and pharmacogenomics; how stem cells and other new tools are helping the development of pharmacogenomics and drug discovery; and an update on the clinical translation of pharmacogenomics to personalized medicine. Part two of this Conference Scene will be featured in the next issue of Pharmacogenomics.

Original language	English
Pages (from-to)	593-599
Number of pages	7
Journal	Pharmacogenomics
Volume	15
Issue number	5
DOIs	https://doi.org/10.2217/pgs.14.35
State	Published - Apr 2014

Access to Document

10.2217/pgs.14.35

Cite this

@article{3f8b13ce79164f4b9e9e829b0285d700,

title = "Conference scene",

abstract = "The second international European Society of Pharmacogenomics and Theranostics (ESPT) conference was organized in Lisbon, Portugal, and attracted 250 participants from 37 different countries. The participants could listen to 50 oral presentations, participate in five lunch symposia and were able to view 83 posters and an exhibition. The first part of this Conference Scene will focus on the pharmacogenomics and biomarkers used in medical oncology, and in particular solid tumors. In addition, this article covers the two keynote conference introductory lectures by Ann K Daly and Magnus Ingelman-Sundberg. The second part of this article will discuss the clinical implementation of pharmacogenomic tests; the role of transports and pharmacogenomics; how stem cells and other new tools are helping the development of pharmacogenomics and drug discovery; and an update on the clinical translation of pharmacogenomics to personalized medicine. Part two of this Conference Scene will be featured in the next issue of Pharmacogenomics.",

author = "G{\'e}rard Siest and Rui Medeiros and Bohuslav Melichar and Maria Stathopoulou and {Van Schaik}, {Ron H.N.} and Ramon Cacabelos and Abt, {Peter Meier} and Carolino Monteiro and David Gurwitz and Jao Queiroz and Helder Mota-Filipe and Ndiaye, {Ndieye Coumba} and Sophie Visvikis-Siest",

year = "2014",

month = apr,

doi = "10.2217/pgs.14.35",

language = "אנגלית",

volume = "15",

pages = "593--599",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

TY - JOUR

T1 - Conference scene

AU - Siest, Gérard

AU - Medeiros, Rui

AU - Melichar, Bohuslav

AU - Stathopoulou, Maria

AU - Van Schaik, Ron H.N.

AU - Cacabelos, Ramon

AU - Abt, Peter Meier

AU - Monteiro, Carolino

AU - Gurwitz, David

AU - Queiroz, Jao

AU - Mota-Filipe, Helder

AU - Ndiaye, Ndieye Coumba

AU - Visvikis-Siest, Sophie

PY - 2014/4

Y1 - 2014/4

N2 - The second international European Society of Pharmacogenomics and Theranostics (ESPT) conference was organized in Lisbon, Portugal, and attracted 250 participants from 37 different countries. The participants could listen to 50 oral presentations, participate in five lunch symposia and were able to view 83 posters and an exhibition. The first part of this Conference Scene will focus on the pharmacogenomics and biomarkers used in medical oncology, and in particular solid tumors. In addition, this article covers the two keynote conference introductory lectures by Ann K Daly and Magnus Ingelman-Sundberg. The second part of this article will discuss the clinical implementation of pharmacogenomic tests; the role of transports and pharmacogenomics; how stem cells and other new tools are helping the development of pharmacogenomics and drug discovery; and an update on the clinical translation of pharmacogenomics to personalized medicine. Part two of this Conference Scene will be featured in the next issue of Pharmacogenomics.

AB - The second international European Society of Pharmacogenomics and Theranostics (ESPT) conference was organized in Lisbon, Portugal, and attracted 250 participants from 37 different countries. The participants could listen to 50 oral presentations, participate in five lunch symposia and were able to view 83 posters and an exhibition. The first part of this Conference Scene will focus on the pharmacogenomics and biomarkers used in medical oncology, and in particular solid tumors. In addition, this article covers the two keynote conference introductory lectures by Ann K Daly and Magnus Ingelman-Sundberg. The second part of this article will discuss the clinical implementation of pharmacogenomic tests; the role of transports and pharmacogenomics; how stem cells and other new tools are helping the development of pharmacogenomics and drug discovery; and an update on the clinical translation of pharmacogenomics to personalized medicine. Part two of this Conference Scene will be featured in the next issue of Pharmacogenomics.

UR - http://www.scopus.com/inward/record.url?scp=84899803345&partnerID=8YFLogxK

U2 - 10.2217/pgs.14.35

DO - 10.2217/pgs.14.35

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:84899803345

SN - 1462-2416

VL - 15

SP - 593

EP - 599

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 5

ER -

Conference scene

Abstract

Access to Document

Other files and links

Fingerprint

Cite this